Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component
- 1 January 2006
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 19 (1), 59-68
- https://doi.org/10.1038/modpathol.3800482
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal CancerClinical Cancer Research, 2005
- Cytoplasmic Phospholipase A2 Levels Correlate with Apoptosis in Human Colon TumorigenesisClinical Cancer Research, 2005
- Signet ring cell carcinoma of the colorectum: correlations between microsatellite instability, clinicopathologic features and survivalLaboratory Investigation, 2005
- Cyclooxygenase-2 and Epidermal Growth Factor Receptor: Pharmacologic Targets for ChemopreventionJournal of Clinical Oncology, 2005
- Celecoxib But Not Rofecoxib Inhibits the Growth of Transformed Cells in Vitro Clinical Cancer Research, 2004
- Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomasInternational Journal of Cancer, 2003
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathwayOncogene, 2000
- Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcomeZeitschrift für Krebsforschung und Klinische Onkologie, 1996